|Age at vaccination||Vaccine||Number of doses||Booster||Notes|
|≥2 months to <18 years||JEspect||2 doses (28 days apart)||No recommendation||
Each dose of JEspect in infants and children aged ≥2 months to <3 years is 0.25 mL.
There are no data to inform recommendations for booster doses in infants and children <18 years. Consider a booster if the child needs sustained protection.
|≥9 months to <18 years||Imojev||1 dose||1–2 years after primary dose if ongoing risk of JE virus exposure||None|
|≥18 years||Imojev||1 dose||Not required||Seroprotective antibody levels persist in most adults 5 years after a single dose of Imojev.5|
|JEspect||2 doses (28 days apart)||1–2 years after primary dose if ongoing risk of JE virus exposure||Adults can receive an accelerated primary course of JEspect (2 × 0.5 mL doses, 7 days apart) if they are at imminent risk of exposure to JE virus.|
- Japanese encephalitis
Printed content may be out of date. For up to date information, always refer to the digital version: https://immunisationhandbook.health.gov.au/resources/handbook-tables/table-recommended-doses-of-japanese-encephalitis-vaccines.